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In Vitro Assessment of IL-4- or IL-13-Mediated
Changes in the Structural Components of
Keratinocytes in Mice and Humans
Miyuki Omori-Miyake1, Masakatsu Yamashita2,4, Yuichiro Tsunemi3, Makoto Kawashima3 and Junji Yagi1
T helper type 2 (Th2) cytokines, IL-4 and IL-13, attenuate the expression of genes that regulate epidermal cellular
structures and the barrier function at the terminal stage of keratinocyte differentiation. However, whether these
Th2 cytokines act at earlier stages remains unknown. We investigated the roles of cytokines in expression levels
of mRNAs and/or proteins in primary mouse keratinocytes and human keratinocyte HaCaT cells at earlier stages.
We showed that IL-4 downregulated the expression levels of Krt1, Krt10, Dsg1, and Dsc1 via IL-4Ra- and signal
transducer and activator of transcription factor 6 (STAT6)-dependent mechanisms in differentiating mouse
keratinocytes at early stages. As the expression levels of keratin-1 and -10 in the keratinocytes transiently
expressing an active form of STAT6 were not downregulated, STAT6 and other IL-4-induced molecules may
synergistically regulate this expression. The restoration of the downregulated expression levels of Krt1 and Krt10
induced by IL-4 with the MEK (mitogen-activated protein kinase (MAPK)/extracellular signal–regulated kinase
kinase) inhibitor U0126 indicated the involvement of the p44/42 MAPK signaling pathway in the attenuated
expression. IL-13 also downregulated the expression of the four genes. Furthermore, IL-4 or IL-13 caused the
downregulation of these genes in HaCaT cells and promoted the fragmentation of cell sheets with mechanical
stress. Our results showed that IL-4 or IL-13 acted on differentiating keratinocytes in vitro at early stages to
attenuate the gene expression.
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INTRODUCTION
T helper type 2 (Th2)-type immune responses are involved in the
development of atopic dermatitis (AD) and other allergic
diseases (Aleksza et al., 2002; La Grutta et al., 2005). The Th2
cytokine IL-4 and epithelial cytokines, including thymic stromal
lymphopoietin, IL-25, and IL-33, have a role in the initiation
and/or amplification of Th2-type immune responses via Th2 and
nonlymphoid cells (Saenz et al., 2008; Paul and Zhu, 2010;
Saenz et al., 2010). Along with IL-4, the Th2 cytokines IL-5 and
IL-13 are expressed in the lesional skin of AD patients at
significantly higher levels than in the skin of nonatopic
individuals (Hamid et al., 1994; Jeong et al., 2003; Nomura
et al., 2003; Neis et al., 2006). Mice overexpressing these
cytokines develop spontaneous AD and asthma (Lee and Flavell,
2004), whereas the skin-specific overexpression of IL-4 in mice
induces the spontaneous development of AD (Chan et al.,
2001). Therefore, high expression levels of these Th2 cytokines
have a role in the abnormal development of the skin.
The main cellular component of the epidermis in the skin
is keratinocytes, which undergo differentiation from the
basal layer toward the spinous layer and granular layer to
the stratum corneum as they migrate. Keratins are the
structural proteins of keratinocytes and form the intermediate
filament cytoskeleton in the epidermis (Candi et al., 2005).
Proliferating keratinocytes in the basal layer express keratin
(KRT) 5 and KRT14, whereas those in the spinous/granular
layers express KRT1 and KRT10 (Candi et al., 2005; Simpson
et al., 2011). Desmosomal cadherins, i.e., desmogleins (DSGs)
and desmocollins (DSCs), link the intracellular network of KRT
intermediate filaments and connect neighboring keratinocytes
(Candi et al., 2005; Simpson et al., 2011). DSG3 and DSC3
are expressed at the highest level in the basal layer and at the
lowest level in the granular layer, whereas DSG1 is expressed
at the lowest level in the basal layer and at the highest level in
the granular layer and DSC1 is expressed at the lowest level in
the spinous layer and at the highest level in the granular layer
(Simpson et al., 2011).
After the induction of Th2 cytokines in patients with
AD, keratinocytes modify structural components and/or the
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barrier function of the stratum corneum. Attenuated
expression levels of various components, i.e., involucrin,
filaggrin, and loricrin, are detected in AD skin with
abundant IL-13 (Suarez-Farinas et al., 2011) and IL-4- and/or
IL-13-treated human keratinocytes (Howell et al., 2007; Kim
et al., 2008). Even a low level of IL-4 attenuates the expression
levels of Flg, Ivl, and Lor in the mouse epidermis (Sehra et al.,
2010).
Most studies of the roles of Th2 cytokines in structural
components and/or the functions of keratinocytes have
focused on the terminal stage of keratinocyte differentiation
in the stratum corneum (Howell et al., 2007; Kim et al., 2008;
Sehra et al., 2010; Suarez-Farinas et al., 2011). If modified
structures of keratinocytes are present at earlier stages of
differentiation, they may influence subsequent differentiation
events and/or the stability of epidermal integrity. Therefore,
events occurring in layers other than the stratum corneum in a
Th2 cytokine–dominant allergic environment require close
scrutiny. We herein investigated the roles of Th2 cytokines
in vitro in primary mouse keratinocytes and human
keratinocyte HaCaT cells at earlier stages of differentiation.
Our study showed that IL-4 or IL-13 attenuated the
expression levels of genes at early stages of differentiation
in mouse keratinocytes and human keratinocyte HaCaT
cells and disrupted the integrity of cell sheets of human
keratinocyte HaCaT cells. These findings demonstrate that
IL-4 or IL-13 modifies the structural components of keratino-
cytes at both the terminal and earlier stages of differentiation
in vitro. The detailed interplay between macromolecules
during the exposure of keratinocytes to IL-4 or IL-13 that
results in the loss of integrity of the cell architecture remains to
be investigated.
RESULTS
IL-4 attenuates the expression of genes encoding structural
components of primary mouse keratinocytes at early stages
To evaluate the effects of IL-4 on the expression of genes
encoding structural components of differentiating keratino-
cytes in the basal layer through the outer layer of the
epidermis, a series of real-time reverse-transcriptase-PCR
experiments were performed to examine KRT genes, i.e.,
Krt5, Krt14, Krt1, and Krt10 (Figure 1a), and desmosomal
cadherin genes, i.e., Dsg3, Dsc3, Dsg1, and Dsc1 (Figure 1b).
The mRNA expression profiles for KRTs in the keratinocytes
indicated that IL-4 attenuated the Krt1 and Krt10 expression
levels and slightly downregulated the Krt5 and Krt14 expres-
sion levels (Figure 1a). The protein profiles were then
examined for genes that were attenuated in their mRNA
expression levels in the presence of IL-4. The protein expres-
sion levels of KRT1 and KRT10 exhibited the identical pattern,
whereas the expression levels of KRT5 and KRT14 were not
statistically significant (Figure 1c and d). The mRNA expres-
sion levels of Dsg1a and Dsc1 were attenuated in the
keratinocytes stimulated with IL-4, whereas the expression
levels of Dsg3 and Dsc3 did not significantly change
(Figure 1b). In contrast, the pattern of the protein expression
levels of DSG1 and DSC1 did not show any changes in the
differentiating keratinocytes with and without IL-4 (Figure 1e
and f). Therefore, the present study showed that IL-4 down-
regulated the expression levels of both mRNA and proteins of
Krt1 and Krt10 and the expression levels of mRNA only of
Krt5, Krt14, Dsg1a, and Dsc1.
IL-13, but not IL-5, downregulates the mRNA expression levels
of Krt1, Krt10, Dsg1a, and Dsc1 in mouse keratinocytes
In addition to IL-4, IL-5 and IL-13 are strongly associated
with the pathogenesis of AD (Jeong et al., 2003); however,
the effects of these cytokines on the expression of structural
components of keratinocytes remain unknown. We investi-
gated whether IL-5 or IL-13 modifies the expression of genes
encoding structural components of differentiating keratino-
cytes at early stages. Compared with the expression of
keratinocytes without cytokines, the mRNA expression levels
of Krt1 and Krt10 were downregulated by IL-13 to the same
extent or more than that downregulated by IL-4 (Figure 2a). In
addition, IL-13 strongly attenuated the expression of Dsc1
mRNA but only slightly attenuated the expression of Dsgla
mRNA (Figure 2b). In contrast, IL-5 did not affect the mRNA
expression of KRTs or desmosomal components in the present
study (Figure 2a and b). As IL-4 and IL-13 each signal through
the IL-4 receptor-a (IL-4Ra) chain (Wills-Karp and Finkelman,
2008), we examined whether the IL-4Ra chain is required for
the regulation of KRT and desmosomal cadherin genes
induced by IL-4 or IL-13. No reductions in the mRNA
expression of KRTs (Figure 2c) or desmosomal components
(Figure 2d) were detected in Il4ra-deficient keratinocytes,
suggesting that IL-4 and IL-13 both attenuate the expre-
ssion levels of Krt1, Krt10, Dsg1a, and Dsc1 mRNAs via the
IL-4Ra chain.
The STAT6 signaling pathway is essential, but likely insufficient,
for IL-4- or IL-13-mediated changes in the gene expression of
mouse differentiating keratinocytes
Both IL-4 and IL-13 activate STAT6 in human keratinocytes
(David et al., 2001; Bao et al., 2012), and attenuated
mRNA expression levels of Ivl and Lor have been reported
in skin biopsies of Stat6-transgenic mice (Kim et al., 2008). To
evaluate whether the STAT6 signaling pathway is involved
in the IL-4- or IL-13-mediated attenuation of the mRNA
expression of structural components, we analyzed the
expression of KRTs and desmosomal components in
differentiating keratinocytes derived from Stat6-deficient
mice by using real-time reverse-transcriptase-PCR. STAT6
was phosphorylated after stimulation with either IL-4 or IL-
13 at a peak of 10 minutes after adding either one of the
cytokines to differentiating keratinocytes (Figure 3a). In the
presence of IL-4 or IL-13, differentiating keratinocytes derived
from Stat6-deficient mice did not show attenuated mRNA
expression levels of the KRT genes Krt1 and Krt10 (Figure 3b)
or the desmosomal component genes Dsg1a and Dsc1
(Figure 3c). Therefore, the STAT6 signaling pathway as a
target of the IL-4 receptor is essential for IL-4 or IL-13 to
attenuate the mRNA expression levels of Krt1, Krt10, Dsg1a,
and Dsc1.
We then investigated whether STAT6 activation is sufficient
for the attenuated expression of these structural proteins.
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Using the keratinocytes transfected with an empty vector or
the active form of STAT6 (STAT6VT) in an expression vector,
the expression levels of KRT1 and KRT10 were analyzed
by gating transfected cells on flow cytometry. No significant
differences were observed between the empty vector–
transfected cells and the STAT6VT vector–transfected cells
for either KRT1 or KRT10 at the mean fluorescence intensity,
suggesting that the activation of STAT6 by itself is not sufficient
to attenuate the KRT1 and KRT10 expression levels
(Figure 3d).
The p44/42 mitogen-activated protein kinase (MAPK) signaling
pathway is indispensable for IL-4-mediated changes in the
mRNA expression levels of Krt1 and Krt10, but not
IL-4-mediated changes in the mRNA expression of Dsc1, in
mouse keratinocytes
MAPKs are generally involved in proliferation, survival,
differentiation, and cell death (Seger and Krebs, 1995; Eckert
et al., 2002). The p44/42 MAPK signaling pathway is activated
in response to IL-4 or IL-13 in human keratinocyte HaCaT
cells (David et al., 2001). In this study, we examined the
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Figure 1. IL-4 attenuates the expression levels of Krt1, Krt10, Dsg1a, and Dsc1 in differentiating primary mouse keratinocytes. The keratinocytes were
differentiated for 9 days. IL-4 was added for the last 2 days of the culture. A real-time PCR analysis of (a) Krt1, Krt5, Krt10, Krt14, (b) Dsg1a, Dsg3, Dsc1, and Dsc3
with or without IL-4 stimulation. The data were normalized to the Ppia mRNA expression using the comparative CT method. The relative quantity (RQ) of genes is
depicted as the mRNA expression in the differentiating keratinocytes without any cytokines (n¼ 7). Asterisk, statistically significant (a matched-pair analysis). A
western blotting analysis of (c) keratin 1 (KRT1), KRT5, KRT10, KRT14, and actin (n¼3) and (e) desmoglein 1 (DSG1) and desmocollin 1 (DSC1; n¼ 3). The
amount of soluble fraction of each lysate in the right lane is one-third of that presented in the left lane. (d, f) Densitometry plots of c and e. RD, relative density;
asterisk, statistically significant (a matched-pair analysis).
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response(s) of p44/42 MAPK to IL-4 or IL-13 in mouse
differentiating keratinocytes. p44/42 MAPK was phosphory-
lated by IL-4 or IL-13 at a peak of 5 minutes after stimulation
(Figure 4a). As a previous report has shown in human
keratinocytes (David et al., 2001), the phosphorylation of
p42 MAPK was stronger than that of p44 MAPK. We then
evaluated the mRNA expression levels of Krt1, Krt10, Dsg1a,
and Dsc1 after treating keratinocytes with U0126, a specific
inhibitor of MEK (MAPK/extracellular signal–regulated kinase
kinase) that acts upstream of p44/42 MAPK. Compared with
the keratinocytes treated with vehicle in the absence of IL-4
(Figure 4b: DMSO/none), the keratinocytes treated with
vehicle in the presence of IL-4 (Figure 4b: DMSO/IL-4) showed
attenuated mRNA expression levels of Krt1, Krt10, and
Dsc1. However, the attenuated mRNA expression levels of
Krt1 and Krt10 were completely restored in the U0126-treated
keratinocytes, even in the presence of IL-4 (Figure 4b: DMSO/
IL-4 vs. U0126/IL-4). U0126 had no effect on the IL-4-
mediated downregulation of Dsc1 mRNA (Figure 4b:
DMSO/IL-4 vs. U0126/IL-4). Taken together, these data
suggest that the p44/42 MAPK signaling pathway has an
essential role in IL-4-mediated changes in the mRNA expres-
sion levels of Krt1 and Krt10, and possibly Dsg1a, but not
Dsc1, in mouse differentiating keratinocytes.
We also examined whether the IL-4-mediated downregula-
tion of structural components of differentiating keratinocytes
depends on another MAPK, p38. The prolonged exposure of
differentiating mouse keratinocytes to IL-4 or IL-13 resulted in
the phosphorylation of p38 MAPK (Figure 4c). Using an
inhibitor of p38 MAPK SB203580, we examined whether
the p38 MAPK signaling pathway is involved in the attenuated
expression of genes encoding structural components of
differentiating keratinocytes. Unlike that of p44/42 MAPK,
the inhibition of p38 MAPK did not restore the attenuated
mRNA expression levels of Krt1, Krt10, Dsg1, and Dsc1
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Figure 2. Similar to IL-4, IL-13 downregulates the expression of genes
encoding structural components of primary mouse keratinocytes via IL-4
receptor alpha. Keratinocytes obtained from wild-type mice (a, b) and Il4ra-
deficient mice (c, d) were differentiated for 9 days. IL-4, IL-13, or IL-5 was
added for the last 2 days of the culture. A real-time PCR analysis of (a, c) Krt1,
Krt10, (b, d) Dsg1a, and Dsc1 with or without cytokine stimulation (n¼ 4).
Refer to Figure 1 for the normalization of the data and the relative quantities
(RQs) of the genes. Asterisk, statistically significant (one-way analysis of
variance with Dunnett’s post hoc test).
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Figure 3. The signal transducer and activator of transcription factor 6
(STAT6) signaling pathway is essential for the IL-4-mediated attenuation of
the expression of genes encoding structural components of primary mouse
keratinocytes. (a) A western blotting analysis of phospho-STAT6 or total STAT6
(n¼ 3). The keratinocytes were differentiated for 6 days. After overnight
starvation, the cells were stimulated with IL-4 or IL-13 for 10, 20, or
40 minutes. (b, c) A real-time PCR analysis of (b) Krt1, Krt10, (c) Dsg1a, and
Dsc1 with or without IL-4 or IL-13 stimulation (n¼ 4). Stat6-deficient
keratinocytes were differentiated for 9 days. IL-4 or IL-13 was added for the last
2 days of the culture. Refer to Figure 1 for the normalization of the data and the
relative quantities (RQs) of the genes. One-way analysis of variance with
Dunnett’s post hoc test indicated no differences between the cells treated with
or without IL-4 or IL-13. (d) Intracellular staining of keratin 1 (KRT1) and KRT10
(n¼ 3). Only with the secondary antibody was used as a control. The
expression in EGFPþ -transfected cells is depicted.
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induced by IL-4 (Figure 4d: DMSO/IL-4 vs. SB203580/IL-4),
thus demonstrating that the p38 MAPK signaling pathway is
not involved in the regulation of Krt1, Krt10, Dsg1, and Dsc1
mRNA by IL-4.
The presence of IL-4 or IL-13 attenuated the mRNA expression
levels of KRT1, KRT10, DSG1, and DSC1 in human keratinocyte
HaCaT cells and disrupted the integrity of the cell sheets
We investigated the mRNA and protein expression of differ-
entiating human keratinocyte HaCaT cells. The genes KRT1
and KRT10 encoding KRTs and DSG1 and DSC1 encoding
desmosomal cadherins in the keratinocytes were attenuated in
the presence of IL-4 or IL-13, whereas the genes KRT5, KRT14,
DSG3, and DSC3 were expressed at similar or slightly lower
levels than those observed in the control (Figure 5a and b). As
observed with the mRNA expression, the protein expression
levels of KRT1 and KRT10 were also attenuated, whereas the
expression of DSC1 remained at a similar level to that
observed in the control (Figure 5c). According to densitometry
plots (Figure 5c), the expression of DSG1 differed between the
IL-4 and IL-13 treatments, and the results showed that the
expression of DSG1 was slightly downregulated by IL-13, but
not IL-4, treatment.
We also assessed the effects of the IL-4- or IL-13-mediated
downregulation of genes at early stages on the integrity of
differentiating keratinocytes. Cell sheets of differentiating
keratinocytes cultured in the presence or absence of IL-4 or
IL-13 were dissociated, and the extent of fragmentation by
mechanical stress was analyzed. As shown in Figure 5d, a
larger number of fragments of cell sheets were observed four
times in the cells cultured with either IL-4 or IL-13 than in the
control cells. These data suggest that the presence of IL-4 or IL-
13 disrupts normal processes of differentiation in keratinocytes
and thus the integrity of keratinocyte cell sheets.
DISCUSSION
By using mouse and human keratinocytes in vitro, we herein
reported that IL-4 or IL-13 attenuated the mRNA expression
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Figure 4. IL-4 downregulates the expression of genes encoding structural components of primary mouse keratinocytes via the p44/42 mitogen-activated protein
kinase (MAPK) signaling pathway. A western blotting analysis of phospho-p44/42 MAPK, total p44/42 MAPK (a), phospho-p38 MAPK, or total-p38 MAPK (c)
(n¼ 3). The keratinocytes were differentiated for 6 days. After overnight starvation, the cells were stimulated with IL-4 or IL-13 for 5, 10, or 30 minutes (a) or 15, 30,
or 60 minutes (c). (b, d) A real-time PCR analysis of Krt1, Krt10, Dsg1a, and Dsc1. The keratinocytes were differentiated for 7 days. The cells were treated with
either U0126 (n¼3) or SB203580 (n¼4) and then stimulated with IL-4 for 24 hours. Refer to Figure 1 for the normalization of the data and the relative quantities
(RQs) of the genes. Asterisk, statistically significant (one-way analysis of variance with Dunnett’s post hoc test).
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levels of KRT1, KRT10, DSG1, and DSC1, which encode
structural components of keratinocytes, at early stages. The
attenuated expression was mediated by STAT6 alone or via
both the STAT6 and p44/42 MAPK signaling pathways in
mouse keratinocytes. As observed in various knockout mice
and in vitro assays, the attenuation of these components is
indicative of mild hyperkeratosis, acanthosis, epidermal fragi-
lity, abrogation of the cohesion of a normal stratum corneum,
ulceration of the epidermis, and barrier abnormalities
(Figure 6). Krt10-deficient mice exhibit mild hyperkeratosis
and acanthosis in the epidermis (Reichelt and Magin, 2002).
The deletion of both Krt1 and Krt10 in mice demonstrates that
both genes are essential for epidermal stability (Wallace et al.,
2012). IL-4 reduces the cohesiveness of the stratum corneum
and the expression of DSG1 in human differentiating
keratinocytes (Hatano et al., 2013). Mice lacking Dsc1
possess a fragile epidermis and develop acantholysis soon
after birth, whereas adult null mice exhibit ulcerating lesions
resembling chronic dermatitis (Chidgey et al., 2001). A lack
of Flg results in barrier abnormalities and thus reduces the
inflammatory threshold to topical irritants and haptens
(Scharschmidt et al., 2009). The loss of Lor confers temporal
instability of the stratum corneum within 5 days after birth
(Koch et al., 2000). The dissociation assay in the present study
also showed that IL-4 or IL-13 disrupted the integrity of
keratinocyte sheets (Figure 5d), although whether the frag-
mentation of the cell sheets resulted from the disruption of
intercellular adhesion and/or the structural integrity of the cells
themselves remains to be investigated (Seltmann et al., 2013).
Therefore, the present and previous studies suggest that IL-4 or
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Figure 5. IL-4 or IL-13 attenuates the mRNA expression levels of KRT1, KRT10, DSG1, and DSC1 and increases the susceptibility of human keratinocyte HaCaT
cell sheets to mechanical stress. The keratinocytes were differentiated for 5 days. IL-4 or IL-13 was added for the last 2 days of the culture. A real-time PCR analysis
of (a) KRT1, KRT5, KRT10, KRT14, (b) DSG1, DSG3, DSC1, and DSC3 with or without cytokine stimulation. The data were normalized to the TBP mRNA
expression using the comparative CT method. The relative quantities (RQs) of the genes (n¼ 4). Asterisks in a and b, statistically significant (one-way analysis of
variance (ANOVA) with Dunnett’s post hoc test). (c) A western blotting analysis of keratin 1 (KRT1), KRT10, desmoglein 1 (DSG1), desmocollin 1 (DSC1), and actin
(n¼ 3). Densitometry plots are depicted. RD, relative density; asterisk, statistically significant (one-way ANOVA with Dunnett’s post hoc test). (d) The degree of
keratinocyte clustering in the presence or absence of cytokines was depicted (upper) and quantified (bottom) using a dispase-based assay (n¼4). Asterisk,
statistically significant (a matched-pair analysis).
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IL-13 attenuates the expression levels of KRT1, KRT10, DSG1,
and DSC1, as well as filaggrin, loricrin, and involucrin, and
disrupt the normal integrity of the keratinocyte architecture at
earlier stages of mouse and human keratinocyte differentiation
(Figure 6).
As keratinocytes, unlike T cells and B cells, do not express a
common g chain (gc), IL-4 and IL-13 both appear to signal
through the receptor composed of the IL-4Ra and IL-13Ra1
chains (Wery-Zennaro et al., 1999). In the present study, the
expression levels of Krt1, Krt10, Dsg1, and Dsc1 were not
attenuated in the mouse Il4ra- or Stat6-deficient differentiating
keratinocytes. Although the addition of either IL-4 or IL-13
induced the phosphorylation of STAT6 in the differentiating
mouse keratinocytes, the expression levels of KRT1 and KRT10
were not altered upon transfection of the cells with an active
form of STAT6 (Figure 3d). Therefore, our data suggest that
STAT6 may require other unknown IL-4- or IL-13-mediated sig-
nals, possibly the p44/42 MAPK signaling pathway (Figure 4b),
to allow the IL-4- or IL-13-mediated regulation of the Krt1,
Krt10, and Dsg1a expression levels. Whether the expression of
Dsc1 requires the activation of STAT6 alone or a combination
of STAT6 and other factors remains to be investigated (Figure 6).
The p38 MAPK pathway does not appear to be involved in the
IL-4-mediated attenuation of KRTs and desmosomal cadherins,
whereas the activation of p38 MAPK results in blister forma-
tion via the internalization of Dsg3 and Dsc3 (Mao et al.,
2011). Whether the signal pathways we investigated in mouse
keratinocytes are identical to those observed in human
keratinocytes remains to be investigated.
In our in vitro study, IL-4 did not clearly downregulate the
protein expression of DSG1 or DSC1, whereas IL-13 down-
regulated the protein expression of DSG1 only, according to
the densitometry plots (Figure 5c). In fact, differentiated
human keratinocyte HaCaT cells that were cultured for a long
time (12 days) did not show a different expression of DSC1
between cells treated with or without IL-4 or IL-13
(Supplementary Figure S1 online). As IL-4 or IL-13 down-
regulated the mRNA expression levels of both genes, our
results of the protein expression of both genes raise a question
regarding the regulatory interplay of DSG1 and DSC1 invol-
ving the transcription, translation, and turnover of mRNA and
proteins during the exposure of keratinocytes to IL-4 or IL-13.
Furthermore, the attenuated expression levels of Dsg1a and
Dsc1 mRNA in IL-4- or IL-13-stimulated keratinocytes possibly
results from the concomitant attenuation of KRT1 and KRT10
(Wallace et al., 2012). On the other hand, the IL-4- or IL-13-
mediated downregulated expression levels of Krt1, Krt10, and
Dsc1 mRNA may result from the concomitant attenuation of
DSG1 (Harmon et al., 2013). Therefore, a series of studies is
needed to investigate the regulatory network of genes
encoding structural components in the epidermis and the
possible interplay of macromolecules during the exposure of
keratinocytes to IL-4 or IL-13.
MATERIALS AND METHODS
Mice
BALB/c mice and Il4ra-deficient mice were purchased from Charles
River Laboratories Japan (Yokohama, Japan) and Jackson Laboratory
(Bar Harbor, ME), respectively. Dr S. Akira and Dr T. Nakayama
kindly provided the Stat6-deficient mice. The animals were housed in
the animal facility of the Department of Microbiology and Immunol-
ogy, Tokyo Women’s Medical University, Tokyo, Japan. All experi-
ments were performed under the guidelines and protocols approved
by the Animal Care, Use and Ethics Committee for animal experi-
ments and the Safety Committee of Molecular Cloning and Use at the
Tokyo Women’s Medical University.
Keratinocyte cultures
The primary culture of mouse keratinocytes was performed according
to the CELLnTEC protocol (described in the Supplementary Materials
and methods online). The keratinocytes were differentiated in CnT-02
epithelium medium (CELLnTEC, Bern, Switzerland) supplemented
with 1.2 mM CaCl2 for the indicated periods.
Immortalized human keratinocyte HaCaT cells were purchased
from Cosmo Bio (Tokyo, Japan). The cell line was originally
established by Dr Boukamp and Dr Fusenig (Boukamp et al., 1988),
and Deutsches Krebsforschungszentrum (Germany) reserves all rights
for its use. The HaCaT keratinocytes were grown in Dulbecco’s
modified Eagle’s medium (Gibco, Life Technologies, Tokyo, Japan)
containing 10% fetal calf serum in a humidified atmosphere of 5%
CO2 at 37 1C and differentiated in medium containing 1.8 mM CaCl2
for 5 days.
Cytokines and reagents
Either mouse recombinant IL-4 (Wako, Osaka, Japan), IL-5, or IL-13 or
human IL-4 or IL-13 (Peprotech, Rocky Hill, NJ) were used for the
experiments. In the experiments with an inhibitor treatment, the MEK
inhibitor U0126 (Promega, Tokyo, Japan) or the p38 MAPK inhibitor
SB203580 (Calbiochem, Merck Millipore, Tokyo, Japan) was used.
See the Supplementary Materials and methods for more details.
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Figure 6. Schematic representation of IL-4- or IL-13-mediated changes
in the structural components of differentiating keratinocytes. The presentation
was summarized using previously published studies and the present
study. In the presence of IL-4 or IL-13, the expression levels of genes (Krt1,
Krt10, Dsg1, and Dsc1) encoding structural components of differentiating
keratinocytes at early stages is downregulated via the signal transducer and
activator of transcription factor 6 (STAT6) and/or p44/42 mitogen-activated
protein kinase (MAPK) signaling pathways, as compared with the normal
expression levels of these genes. This change may result in epidermal
instability, abrogation of the cohesion of a normal stratum corneum, or
ulcerating lesions, as previously reported (Chidgey et al., 2001; Wallace
et al., 2012; Hatano et al., 2013). IL-4 and/or IL-13 are capable of
downregulating the expression levels of the genes Flg, Lor, and Ivl, which
encode structural components of differentiating keratinocytes at late
stages (Howell et al., 2007; Kim et al., 2008; Sehra et al., 2010). The
attenuated expression levels of Flg and Lor results in barrier abnormalities
and temporal instability, respectively (Koch et al., 2000; Scharschmidt
et al., 2009).
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Semiquantitative real-time reverse-transcriptase–PCR
cDNA was synthesized using SuperScript II (Invitrogen, Life
Technologies) according to the manufacturer’s instructions. Real-time
PCR was performed using the comparative CT method: all data in
mice and humans were normalized to Ppia (encoding cyclophilin A)
and TBP, respectively. The data were expressed as the relative
quantity of the target genes to the untreated or vehicle-treated
keratinocytes. The details are described in the Supplementary
Materials and Methods online.
Western blotting
A western blotting analysis was performed as described in the
Supplementary Materials and methods online. The blots were probed
with anti-KRT1, anti-KRT10, anti-KRT5, anti-KRT14, anti-DSG1, anti-
DSC1 or anti-actin, anti-STAT6, anti-phospho-STAT6 (Thy641), anti-
p44/42 MAPK, anti-phospho-p44/42 MAPK, anti-p38 MAPK, and
anti-phospho-p38 MAPK (Thr180/Thr182) primary antibodies.
Transfection of keratinocytes for intracellular staining of KRTs
Keratinocytes were co-transfected with either pCMV-Myc-STAT6 or
the mock plasmid plus the pEGFP-C1 vector. After transfection, the
cells were used for intracellular KRT staining. The cells were stained
with either anti-KRT1 or anti-KRT10 (Covance, Research Products,
Denver, PA), visualized with Alexa 647–conjugated anti-rabbit Ig
(Molecular Probes, Life Technologies), and analyzed with flow
cytometry on an FACSCalibur flow cytometer (Becton Dickinson
Japan, Tokyo, Japan). See the Supplementary Materials and Methods
online for details.
Dispase-based keratinocyte dissociation assay
The dispase-based keratinocyte dissociation assay was partially mod-
ified from a previous study (Heupel et al., 2009), as described in the
Supplementary Materials and Methods online. Human keratinocyte
HaCaT cells were labeled with CFSE (carboxyfluorescein succinimidyl
ester), washed, and incubated with dispase II for 30 minutes at 37 1C.
After carefully removing the dispase solution, 0.5 ml of Hank’s
Balanced Salt Solution was added. The cell layer was pipetted 10
times with a 1-ml pipette at a constant speed. The cells were observed
under a BZ-9000 fluorescence microscope (Keyence, Osaka, Japan).
Statistical analysis
Differences between the two groups were tested using matched-pair
analyses, whereas differences among multiple groups were tested
using one-way analysis of variance with Dunnett’s post hoc test. All
analyses were performed with the JMP ver. 10.0 software program
(SAS Institute, Cary, NC). The statistical significance is described in
the figures (*Po0.05; **Po0.01; ***Po0.005; ****Po0.001;
*****Po0.0005; ******Po0.0001).
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